Form SB-2 - Optional form for registration of securities to be sold to the public by small business issuers:
SEC Accession No. 0000912057-01-522171
Filing Date
2001-06-29
Accepted
2001-06-29 00:00:00
Documents
9

Document Format Files

Seq Description Document Type Size
1 SB-2 a2053052zsb-2.txt SB-2 348574
2 EXHIBIT 3.1 a2053052zex-3_1.txt EX-3.1 21365
3 EXHIBIT 3.2 a2053052zex-3_2.txt EX-3.2 40962
4 EXHIBIT 4.2 a2053052zex-4_2.txt EX-4.2 37185
5 EXHIBIT 5.1 a2053052zex-5_1.txt EX-5.1 3157
6 EXHIBIT 10.3 a2053052zex-10_3.txt EX-10.3 36638
7 EXHIBIT 10.20 a2053052zex-10_20.txt EX-10.20 108510
8 EXHIBIT 23.1 a2053052zex-23_1.txt EX-23.1 480
9 EXHIBIT 23.2 a2053052zex-23_2.txt EX-23.2 448
  Complete submission text file 0000912057-01-522171.txt   599845
Mailing Address 175 OLDE HALF DAY ROAD SUITE 123 LINCOLNSHIRE IL 60069
Business Address 175 OLDE HALF DAY ROAD SUITE 123 LINCOLNSHIRE IL 60069 8477932458
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: WY | Fiscal Year End: 1231
Type: SB-2 | Act: 33 | File No.: 333-64218 | Film No.: 1672463
SIC: 2836 Biological Products, (No Diagnostic Substances)